Development of antimicrobials for wound care: In-vitro and in-vivo assessments

Stephen C Davis, Navid Bouzari

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In the development of antimicrobial agents, the use of both in-vitro and in-vivo models is essential for successful outcomes. In-vitro tests are necessary to help determine initial dose-response data as well as to evaluate potential susceptibility and/or resistance of specific pathogens. The employment of appropriate in-vivo animal testing is vital prior to clinical evaluations, since factors, such as wound fluid, growth factors, etc., need to be taken into account. When performing both of these types of evaluations (in vitro and in vivo), one also needs to be aware of which bacteria form is being studied, e.g., free floating (planktonic) or biofilm. This is especially critical, since bacteria living in a biofilm have been shown to be more resistant to therapies. The translation of in-vitro and in-vivo studies from the laboratory into the clinic is necessary to obtain successful antimicrobial therapeutics.

Original languageEnglish
Pages (from-to)344-347
Number of pages4
JournalWounds
Volume16
Issue number11
StatePublished - Nov 1 2004

Fingerprint

Wounds and Injuries
Biofilms
Bacteria
Anti-Infective Agents
Intercellular Signaling Peptides and Proteins
In Vitro Techniques
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Development of antimicrobials for wound care : In-vitro and in-vivo assessments. / Davis, Stephen C; Bouzari, Navid.

In: Wounds, Vol. 16, No. 11, 01.11.2004, p. 344-347.

Research output: Contribution to journalArticle

@article{44761031590a48e3a3bc4890e28775d5,
title = "Development of antimicrobials for wound care: In-vitro and in-vivo assessments",
abstract = "In the development of antimicrobial agents, the use of both in-vitro and in-vivo models is essential for successful outcomes. In-vitro tests are necessary to help determine initial dose-response data as well as to evaluate potential susceptibility and/or resistance of specific pathogens. The employment of appropriate in-vivo animal testing is vital prior to clinical evaluations, since factors, such as wound fluid, growth factors, etc., need to be taken into account. When performing both of these types of evaluations (in vitro and in vivo), one also needs to be aware of which bacteria form is being studied, e.g., free floating (planktonic) or biofilm. This is especially critical, since bacteria living in a biofilm have been shown to be more resistant to therapies. The translation of in-vitro and in-vivo studies from the laboratory into the clinic is necessary to obtain successful antimicrobial therapeutics.",
author = "Davis, {Stephen C} and Navid Bouzari",
year = "2004",
month = "11",
day = "1",
language = "English",
volume = "16",
pages = "344--347",
journal = "Wounds",
issn = "1044-7946",
publisher = "HMP Communications",
number = "11",

}

TY - JOUR

T1 - Development of antimicrobials for wound care

T2 - In-vitro and in-vivo assessments

AU - Davis, Stephen C

AU - Bouzari, Navid

PY - 2004/11/1

Y1 - 2004/11/1

N2 - In the development of antimicrobial agents, the use of both in-vitro and in-vivo models is essential for successful outcomes. In-vitro tests are necessary to help determine initial dose-response data as well as to evaluate potential susceptibility and/or resistance of specific pathogens. The employment of appropriate in-vivo animal testing is vital prior to clinical evaluations, since factors, such as wound fluid, growth factors, etc., need to be taken into account. When performing both of these types of evaluations (in vitro and in vivo), one also needs to be aware of which bacteria form is being studied, e.g., free floating (planktonic) or biofilm. This is especially critical, since bacteria living in a biofilm have been shown to be more resistant to therapies. The translation of in-vitro and in-vivo studies from the laboratory into the clinic is necessary to obtain successful antimicrobial therapeutics.

AB - In the development of antimicrobial agents, the use of both in-vitro and in-vivo models is essential for successful outcomes. In-vitro tests are necessary to help determine initial dose-response data as well as to evaluate potential susceptibility and/or resistance of specific pathogens. The employment of appropriate in-vivo animal testing is vital prior to clinical evaluations, since factors, such as wound fluid, growth factors, etc., need to be taken into account. When performing both of these types of evaluations (in vitro and in vivo), one also needs to be aware of which bacteria form is being studied, e.g., free floating (planktonic) or biofilm. This is especially critical, since bacteria living in a biofilm have been shown to be more resistant to therapies. The translation of in-vitro and in-vivo studies from the laboratory into the clinic is necessary to obtain successful antimicrobial therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=10444274149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10444274149&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:10444274149

VL - 16

SP - 344

EP - 347

JO - Wounds

JF - Wounds

SN - 1044-7946

IS - 11

ER -